NCT00394537View on ClinicalTrials.gov

Labetalol to Prevent Hypertension and Tachycardia During Fiberoptic Bronchoscopy

PHASE4CompletedINTERVENTIONAL

Enrollment

72

Participants

Timeline

Start Date

Not specified

Study Completion Date

May 31, 2007

Conditions

Bronchoscopy

Interventions

DRUG

Labetalol 10mg iv

Trial Locations (1)

49100

Rabin Medical Center, Petah Tikva

All Listed Sponsors

lead

Rabin Medical Center

OTHER

NCT00394537 - Labetalol to Prevent Hypertension and Tachycardia During Fiberoptic Bronchoscopy | Biotech Hunter | Biotech Hunter